Literature DB >> 36033934

Chimeric antigen receptor T-cell therapy in adults: management of toxicities and implications for critical care.

F Haseeb1, E Tholouli1, A Wilson1.   

Abstract

Entities:  

Keywords:  adoptive immunotherapy; bone marrow failure; chimeric antigen receptors; cytokine storm syndrome; intensive care; multiple organ failure

Year:  2022        PMID： 36033934      PMCID： PMC9402785          DOI： 10.1016/j.bjae.2022.04.001

Source DB:  PubMed          Journal:  BJA Educ        ISSN： 2058-5349


× No keyword cloud information.
  11 in total

1.  Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.

Authors:  Michael Crump; Sattva S Neelapu; Umar Farooq; Eric Van Den Neste; John Kuruvilla; Jason Westin; Brian K Link; Annette Hay; James R Cerhan; Liting Zhu; Sami Boussetta; Lei Feng; Matthew J Maurer; Lynn Navale; Jeff Wiezorek; William Y Go; Christian Gisselbrecht
Journal:  Blood       Date:  2017-08-03       Impact factor: 22.113

2.  Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Authors:  Stephen J Schuster; Michael R Bishop; Constantine S Tam; Edmund K Waller; Peter Borchmann; Joseph P McGuirk; Ulrich Jäger; Samantha Jaglowski; Charalambos Andreadis; Jason R Westin; Isabelle Fleury; Veronika Bachanova; S Ronan Foley; P Joy Ho; Stephan Mielke; John M Magenau; Harald Holte; Serafino Pantano; Lida B Pacaud; Rakesh Awasthi; Jufen Chu; Özlem Anak; Gilles Salles; Richard T Maziarz
Journal:  N Engl J Med       Date:  2018-12-01       Impact factor: 91.245

3.  [Management of CAR-T cell-related encephalopathy syndrome in adult and pediatric patients: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].

Authors:  Jérôme Cornillon; Nawal Hadhoum; Gabrielle Roth-Guepin; Asmaa Quessar; Lara Platon; Marie Ouachée-Chardin; Emmanuelle Nicolas-Virelizier; Jérôme Naudin; Anne-Sophie Moreau; Stavroula Masouridi-Levrat; Cécile Borel; Imran Ahmad; David Beauvais; André Baruchel; Ibrahim Yakoub-Agha
Journal:  Bull Cancer       Date:  2019-06-13       Impact factor: 1.276

4.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

Review 5.  Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Authors:  Sattva S Neelapu; Sudhakar Tummala; Partow Kebriaei; William Wierda; Cristina Gutierrez; Frederick L Locke; Krishna V Komanduri; Yi Lin; Nitin Jain; Naval Daver; Jason Westin; Alison M Gulbis; Monica E Loghin; John F de Groot; Sherry Adkins; Suzanne E Davis; Katayoun Rezvani; Patrick Hwu; Elizabeth J Shpall
Journal:  Nat Rev Clin Oncol       Date:  2017-09-19       Impact factor: 66.675

6.  Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Authors:  Sattva S Neelapu; Frederick L Locke; Nancy L Bartlett; Lazaros J Lekakis; David B Miklos; Caron A Jacobson; Ira Braunschweig; Olalekan O Oluwole; Tanya Siddiqi; Yi Lin; John M Timmerman; Patrick J Stiff; Jonathan W Friedberg; Ian W Flinn; Andre Goy; Brian T Hill; Mitchell R Smith; Abhinav Deol; Umar Farooq; Peter McSweeney; Javier Munoz; Irit Avivi; Januario E Castro; Jason R Westin; Julio C Chavez; Armin Ghobadi; Krishna V Komanduri; Ronald Levy; Eric D Jacobsen; Thomas E Witzig; Patrick Reagan; Adrian Bot; John Rossi; Lynn Navale; Yizhou Jiang; Jeff Aycock; Meg Elias; David Chang; Jeff Wiezorek; William Y Go
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

Review 7.  The myth of the second remission of acute leukemia in the adult.

Authors:  Stephen J Forman; Jacob M Rowe
Journal:  Blood       Date:  2012-12-14       Impact factor: 22.113

Review 8.  ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.

Authors:  Daniel W Lee; Bianca D Santomasso; Frederick L Locke; Armin Ghobadi; Cameron J Turtle; Jennifer N Brudno; Marcela V Maus; Jae H Park; Elena Mead; Steven Pavletic; William Y Go; Lamis Eldjerou; Rebecca A Gardner; Noelle Frey; Kevin J Curran; Karl Peggs; Marcelo Pasquini; John F DiPersio; Marcel R M van den Brink; Krishna V Komanduri; Stephan A Grupp; Sattva S Neelapu
Journal:  Biol Blood Marrow Transplant       Date:  2018-12-25       Impact factor: 5.742

9.  Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL.

Authors:  Nirali N Shah; Daniel W Lee; Bonnie Yates; Constance M Yuan; Haneen Shalabi; Staci Martin; Pamela L Wolters; Seth M Steinberg; Eva H Baker; Cindy P Delbrook; Maryalice Stetler-Stevenson; Terry J Fry; David F Stroncek; Crystal L Mackall
Journal:  J Clin Oncol       Date:  2021-03-25       Impact factor: 44.544

10.  Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.

Authors:  Bianca D Santomasso; Loretta J Nastoupil; Sherry Adkins; Christina Lacchetti; Bryan J Schneider; Milan Anadkat; Michael B Atkins; Kelly J Brassil; Jeffrey M Caterino; Ian Chau; Marianne J Davies; Marc S Ernstoff; Leslie Fecher; Pauline Funchain; Ishmael Jaiyesimi; Jennifer S Mammen; Jarushka Naidoo; Aung Naing; Tanyanika Phillips; Laura D Porter; Cristina A Reichner; Carole Seigel; Jung-Min Song; Alexander Spira; Maria Suarez-Almazor; Umang Swami; John A Thompson; Praveen Vikas; Yinghong Wang; Jeffrey S Weber; Kathryn Bollin; Monalisa Ghosh
Journal:  J Clin Oncol       Date:  2021-11-01       Impact factor: 50.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.